Houston is the ninth worst U.S. metro for ozone pollution, but the future isn't foggy. Electric vehicles can improve air quality by 50 percent. Getty Images

Let's clear the air about Houston's air pollution: A recent report from the American Lung Association ranks Houston the ninth worst U.S. metro area for ozone pollution and the 17th worst in the broad category of long-term particle pollution.

Yet the future might not be so cloudy for Houston's atmosphere.

A newly published study in the journal Atmospheric Environment indicates that replacing at least 35 percent of Houston's gas- and diesel-powered cars and trucks with electric vehicles by 2040 could improve air quality by 50 percent. And if electric vehicles replaced 75 percent of traditional cars and trucks by 2040, air quality could improve by 75 percent, according to the study.

This conversion to electric vehicles would enable residents of the Houston area to "breathe easier, live longer, and enjoy a better economy," the researchers say.

"The population in 2040 Houston will see a huge increase, but we can apply new technology to reduce emissions, improve air quality, and think about health," says one of the researchers, Shuai Pan, a postdoctoral associate in civil and environmental engineering at Cornell University.

Pan earned a doctoral degree in atmospheric science from the University of Houston in 2017.

Kevin Douglass, president of the Houston Electric Auto Association, tells InnovationMap that the study does a good job of emphasizing "the alarming situation that Houston is in with reference to its air quality and how electrification of the transportation system is a … way to improve the bad-air-quality situation."

The nonprofit Houston Electric Auto Association comprises EV owners, hobbyists, educators, and enthusiasts who promote the benefits of these vehicles.

Douglass says he's confident about the progression of the EV evolution in Houston.

"It only took a decade to go from horse-drawn carriage to automobile in the U.S.," he says. "One and a half decades from now, in 2035, at least half of the cars on the road will be electric. Thirty years from now, the vast majority of vehicles will be electric and autonomous."

Houston — which the nonprofit Smart Energy Consumer Collaborative praises as one of the 10 friendliest U.S. cities for EVs — already is on the road toward enhancing air quality by putting more electric vehicles (EVs) on the road. In fact, a 2018 report from the Environment Texas Research and Policy Center predicts the number of EVs in Houston will rise to 65,000 by 2030.

An estimated 9,500 EVs were being driven by Houston motorists in 2018, according to a presentation given in May by Michael Conklin, external engagement manager at Houston-based utility CenterPoint Energy. And by 2028, that number could reach 110,000, the presentation says.

"Electric cars aren't the future — they're already here, and they work," Douglass said in 2018. "As more people learn about them, they will enjoy owning and driving them."

Among Houston's highest-profile EV champions is Mayor Sylvester Turner, who's leading the charge to shift the city-owned fleet away from traditional vehicles and toward hybrids and EVs.

"Transportation is responsible for 48 percent of Houston's greenhouse gas emissions — the highest per capita of all U.S. cities — and something we must address to move our city forward," Turner, co-chair of the Climate Mayors organization, said in 2018.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.